PriceTargets.com logo

The Ensign Group - ENSG Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $119.20
  • Forecasted Upside: 2.34%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$116.48 As of 04/18/2024 01:00 AM ET
▼ -1.34 (-1.14%)

This chart shows the closing price for ENSG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New The Ensign Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ENSG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ENSG

Analyst Price Target is $119.20
▲ +2.34% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for The Ensign Group in the last 3 months. The average price target is $119.20, with a high forecast of $133.00 and a low forecast of $110.00. The average price target represents a 2.34% upside from the last price of $116.48.

This chart shows the closing price for ENSG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 5 investment analysts is to moderate buy stock in The Ensign Group. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/24/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/22/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/20/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/20/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/6/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$112.00 ➝ $133.00Low
2/2/2024OppenheimerBoost TargetOutperform ➝ Outperform$127.00 ➝ $130.00Low
1/17/2024OppenheimerBoost TargetOutperform ➝ Outperform$115.00 ➝ $127.00Low
10/27/2023StephensBoost TargetOverweight ➝ Overweight$112.00 ➝ $113.00Low
9/28/2023Berenberg BankInitiated CoverageBuy$110.00Low
9/13/2023Truist FinancialReiterated RatingHold ➝ Hold$110.00Low
9/5/2023Truist FinancialReiterated RatingHold ➝ Hold$110.00Low
8/15/2023StephensReiterated RatingOverweight ➝ Overweight$110.00Low
7/31/2023Royal Bank of CanadaBoost TargetOutperform$108.00 ➝ $114.00Low
5/1/2023Royal Bank of CanadaBoost Target$102.00 ➝ $108.00Low
4/13/2023Truist FinancialBoost TargetHold$105.00 ➝ $110.00Low
2/3/2023OppenheimerBoost TargetOutperform$110.00 ➝ $115.00Low
1/19/2023OppenheimerBoost TargetOutperform$105.00 ➝ $110.00Low
11/1/2022OppenheimerBoost Target$105.00Low
11/1/2022Royal Bank of CanadaBoost TargetOutperform$95.00 ➝ $102.00Low
10/28/2022StephensBoost TargetOverweight$100.00 ➝ $101.00Low
9/15/2022Stifel NicolausBoost TargetBuy$100.00 ➝ $105.00Low
8/3/2022Royal Bank of CanadaLower TargetOutperform$101.00 ➝ $95.00N/A
8/3/2022Truist FinancialBoost Target$85.00 ➝ $95.00Low
7/14/2022Truist FinancialLower TargetHold$90.00 ➝ $85.00Low
4/7/2022Truist FinancialBoost Target$90.00 ➝ $98.00Low
11/11/2021Truist FinancialBoost TargetHold$82.00 ➝ $90.00Low
10/29/2021Royal Bank of CanadaLower TargetOutperform$100.00 ➝ $96.00Medium
10/28/2021Stifel NicolausBoost TargetBuy$87.00 ➝ $96.00High
10/13/2021Truist FinancialLower TargetHold$90.00 ➝ $80.00Low
8/23/2021Truist FinancialLower TargetHold$98.00 ➝ $90.00Low
6/22/2021Stifel NicolausInitiated CoverageBuyLow
5/3/2021Royal Bank of CanadaBoost TargetOutperform$95.00 ➝ $100.00Medium
4/14/2021Truist FinancialBoost Target$90.00 ➝ $98.00Low
3/15/2021Royal Bank of CanadaBoost TargetOutperform$91.00 ➝ $95.00Medium
1/5/2021Truist FinancialBoost Target$64.00 ➝ $82.00N/A
11/11/2020StephensUpgradeEqual Weight ➝ Overweight$61.00 ➝ $79.00Medium
8/5/2020OppenheimerReiterated RatingBuy$60.00High
6/11/2020SunTrust BanksBoost TargetHold$46.00 ➝ $50.00High
5/21/2020SunTrust BanksBoost TargetHold$44.00 ➝ $46.00Medium
5/12/2020StephensReiterated RatingHold$40.00Medium
4/20/2020Royal Bank of CanadaReiterated RatingBuy$48.00Low
4/13/2020SunTrust BanksLower TargetHold$55.00 ➝ $44.00High
2/6/2020CitigroupBoost TargetOutperform$53.00 ➝ $60.00High
12/18/2019SunTrust BanksBoost TargetHold$44.00 ➝ $48.00Medium
11/1/2019Royal Bank of CanadaSet TargetBuy$50.00Medium
11/1/2019StephensSet TargetHold$47.00Medium
10/31/2019Stifel NicolausUpgradeHold ➝ Buy$56.00 ➝ $51.00Medium
10/22/2019StephensReiterated RatingEqual Weight$45.00Medium
10/21/2019StephensInitiated CoverageEqual Weight$45.00Medium
9/26/2019OppenheimerSet TargetBuy$64.00High
8/2/2019Stifel NicolausBoost TargetHold$52.00 ➝ $56.00High
5/8/2019OppenheimerBoost TargetOutperform$52.00 ➝ $58.00Low
(Data available from 4/19/2019 forward)

News Sentiment Rating

1.37 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 10 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2023
  • 8 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 3 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2023
  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
12/21/2023
  • 8 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/20/2024
  • 20 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2024
  • 18 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2024
  • 16 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 16 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

The Ensign Group logo
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The company's Skilled Services segment engages in the operation of skilled nursing facilities and rehabilitation therapy services for patients with chronic conditions, prolonged illness, and the elderly; and offers nursing facilities including specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management, as well as standard services comprising room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. Its Standard Bearer segment is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. In addition, the company provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. It operates in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Read More

Today's Range

Now: $116.48
Low: $115.68
High: $118.12

50 Day Range

MA: $122.05
Low: $116.48
High: $125.99

52 Week Range

Now: $116.48
Low: $87.14
High: $127.57

Volume

265,277 shs

Average Volume

265,102 shs

Market Capitalization

$6.63 billion

P/E Ratio

31.83

Dividend Yield

0.20%

Beta

0.94

Frequently Asked Questions

What sell-side analysts currently cover shares of The Ensign Group?

The following Wall Street research analysts have issued research reports on The Ensign Group in the last twelve months: Berenberg Bank, Oppenheimer Holdings Inc., Royal Bank of Canada, Stephens, StockNews.com, and Truist Financial Co..
View the latest analyst ratings for ENSG.

What is the current price target for The Ensign Group?

5 Wall Street analysts have set twelve-month price targets for The Ensign Group in the last year. Their average twelve-month price target is $119.20, suggesting a possible upside of 2.3%. Royal Bank of Canada has the highest price target set, predicting ENSG will reach $133.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $110.00 for The Ensign Group in the next year.
View the latest price targets for ENSG.

What is the current consensus analyst rating for The Ensign Group?

The Ensign Group currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for ENSG.

What other companies compete with The Ensign Group?

Other companies that are similar to The Ensign Group include Inspire Medical Systems, Elanco Animal Health, Vaxcyte, Acadia Healthcare and Jazz Pharmaceuticals. Learn More about companies similar to The Ensign Group.

How do I contact The Ensign Group's investor relations team?

The Ensign Group's physical mailing address is 29222 RANCHO VIEJO RD. SUITE 127, SAN JUAN CAPISTRANO CA, 92675. The company's listed phone number is (949) 487-9500 and its investor relations email address is [email protected]. The official website for The Ensign Group is www.ensigngroup.net. Learn More about contacing The Ensign Group investor relations.